nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Ifosfamide—testicular cancer	0.165	0.204	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.165	0.204	CbGbCtD
Dextropropoxyphene—CYP2C8—Ifosfamide—testicular cancer	0.119	0.147	CbGbCtD
Dextropropoxyphene—CYP2C9—Ifosfamide—testicular cancer	0.0828	0.103	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—testicular cancer	0.0567	0.0705	CbGbCtD
Dextropropoxyphene—CYP3A4—Ifosfamide—testicular cancer	0.0481	0.0598	CbGbCtD
Dextropropoxyphene—CYP2C9—Cisplatin—testicular cancer	0.0403	0.05	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinblastine—testicular cancer	0.0402	0.0499	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinblastine—testicular cancer	0.0255	0.0317	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—testicular cancer	0.0247	0.0307	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—testicular cancer	0.023	0.0286	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—testicular cancer	0.0157	0.0195	CbGbCtD
Dextropropoxyphene—Mediastinal disorder—Ifosfamide—testicular cancer	0.000904	0.00463	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Ifosfamide—testicular cancer	0.000896	0.00459	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Chlorambucil—testicular cancer	0.000888	0.00455	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Epirubicin—testicular cancer	0.000884	0.00453	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000881	0.00452	CcSEcCtD
Dextropropoxyphene—Bradycardia—Cisplatin—testicular cancer	0.00088	0.00451	CcSEcCtD
Dextropropoxyphene—Malnutrition—Ifosfamide—testicular cancer	0.000873	0.00448	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Etoposide—testicular cancer	0.00087	0.00446	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Etoposide—testicular cancer	0.000865	0.00443	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—testicular cancer	0.000863	0.00443	CcSEcCtD
Dextropropoxyphene—Jaundice—Etoposide—testicular cancer	0.00086	0.00441	CcSEcCtD
Dextropropoxyphene—Discomfort—Bleomycin—testicular cancer	0.000859	0.0044	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Chlorambucil—testicular cancer	0.000852	0.00436	CcSEcCtD
Dextropropoxyphene—Constipation—Vinblastine—testicular cancer	0.000844	0.00433	CcSEcCtD
Dextropropoxyphene—Confusional state—Bleomycin—testicular cancer	0.000841	0.00431	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Etoposide—testicular cancer	0.000835	0.00428	CcSEcCtD
Dextropropoxyphene—Visual impairment—Cisplatin—testicular cancer	0.000833	0.00427	CcSEcCtD
Dextropropoxyphene—Vision blurred—Ifosfamide—testicular cancer	0.000823	0.00422	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—testicular cancer	0.000818	0.00419	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Vinblastine—testicular cancer	0.000813	0.00417	CcSEcCtD
Dextropropoxyphene—Eye disorder—Cisplatin—testicular cancer	0.000808	0.00414	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—testicular cancer	0.000808	0.00414	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vinblastine—testicular cancer	0.000807	0.00414	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Cisplatin—testicular cancer	0.000802	0.00411	CcSEcCtD
Dextropropoxyphene—Agitation—Ifosfamide—testicular cancer	0.000802	0.00411	CcSEcCtD
Dextropropoxyphene—Discomfort—Dactinomycin—testicular cancer	0.000801	0.00411	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Chlorambucil—testicular cancer	0.000794	0.00407	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Cisplatin—testicular cancer	0.000781	0.004	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vinblastine—testicular cancer	0.00078	0.004	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Cisplatin—testicular cancer	0.000779	0.00399	CcSEcCtD
Dextropropoxyphene—Hypotension—Bleomycin—testicular cancer	0.000779	0.00399	CcSEcCtD
Dextropropoxyphene—Asthenia—Chlorambucil—testicular cancer	0.000773	0.00396	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Cisplatin—testicular cancer	0.000772	0.00396	CcSEcCtD
Dextropropoxyphene—Convulsion—Ifosfamide—testicular cancer	0.000756	0.00388	CcSEcCtD
Dextropropoxyphene—Malnutrition—Cisplatin—testicular cancer	0.000753	0.00386	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—testicular cancer	0.000748	0.00383	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Bleomycin—testicular cancer	0.000743	0.00381	CcSEcCtD
Dextropropoxyphene—Eye disorder—Etoposide—testicular cancer	0.00074	0.00379	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Chlorambucil—testicular cancer	0.000737	0.00378	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Etoposide—testicular cancer	0.000735	0.00377	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—testicular cancer	0.000734	0.00376	CcSEcCtD
Dextropropoxyphene—Discomfort—Ifosfamide—testicular cancer	0.000734	0.00376	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vinblastine—testicular cancer	0.000727	0.00373	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Methotrexate—testicular cancer	0.000724	0.00371	CcSEcCtD
Dextropropoxyphene—Confusional state—Ifosfamide—testicular cancer	0.000718	0.00368	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Etoposide—testicular cancer	0.000715	0.00367	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Etoposide—testicular cancer	0.000714	0.00366	CcSEcCtD
Dextropropoxyphene—Vision blurred—Cisplatin—testicular cancer	0.000709	0.00364	CcSEcCtD
Dextropropoxyphene—Asthenia—Vinblastine—testicular cancer	0.000708	0.00363	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—testicular cancer	0.000708	0.00363	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Ifosfamide—testicular cancer	0.000699	0.00358	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Bleomycin—testicular cancer	0.000687	0.00352	CcSEcCtD
Dextropropoxyphene—Vomiting—Chlorambucil—testicular cancer	0.000685	0.00351	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00068	0.00348	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vinblastine—testicular cancer	0.000675	0.00346	CcSEcCtD
Dextropropoxyphene—Hypotension—Ifosfamide—testicular cancer	0.000666	0.00341	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000655	0.00336	CcSEcCtD
Dextropropoxyphene—Dizziness—Vinblastine—testicular cancer	0.000653	0.00335	CcSEcCtD
Dextropropoxyphene—Convulsion—Cisplatin—testicular cancer	0.000652	0.00334	CcSEcCtD
Dextropropoxyphene—Ataxia—Methotrexate—testicular cancer	0.000645	0.00331	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000642	0.00329	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dactinomycin—testicular cancer	0.000641	0.00328	CcSEcCtD
Dextropropoxyphene—Nausea—Chlorambucil—testicular cancer	0.00064	0.00328	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000636	0.00326	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Ifosfamide—testicular cancer	0.000635	0.00326	CcSEcCtD
Dextropropoxyphene—Somnolence—Ifosfamide—testicular cancer	0.000633	0.00325	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—testicular cancer	0.000633	0.00325	CcSEcCtD
Dextropropoxyphene—Discomfort—Cisplatin—testicular cancer	0.000633	0.00325	CcSEcCtD
Dextropropoxyphene—Vomiting—Vinblastine—testicular cancer	0.000628	0.00322	CcSEcCtD
Dextropropoxyphene—Headache—Vinblastine—testicular cancer	0.000618	0.00317	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000615	0.00315	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dactinomycin—testicular cancer	0.000615	0.00315	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Bleomycin—testicular cancer	0.000614	0.00315	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—testicular cancer	0.00061	0.00313	CcSEcCtD
Dextropropoxyphene—Constipation—Ifosfamide—testicular cancer	0.000609	0.00312	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Etoposide—testicular cancer	0.000606	0.00311	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—testicular cancer	0.000604	0.00309	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Cisplatin—testicular cancer	0.000602	0.00309	CcSEcCtD
Dextropropoxyphene—Tachycardia—Cisplatin—testicular cancer	0.0006	0.00307	CcSEcCtD
Dextropropoxyphene—Asthenia—Bleomycin—testicular cancer	0.000598	0.00307	CcSEcCtD
Dextropropoxyphene—Convulsion—Etoposide—testicular cancer	0.000597	0.00306	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000594	0.00304	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—testicular cancer	0.000593	0.00304	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Ifosfamide—testicular cancer	0.000587	0.00301	CcSEcCtD
Dextropropoxyphene—Nausea—Vinblastine—testicular cancer	0.000586	0.00301	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000583	0.00299	CcSEcCtD
Dextropropoxyphene—Discomfort—Etoposide—testicular cancer	0.00058	0.00297	CcSEcCtD
Dextropropoxyphene—Hypotension—Cisplatin—testicular cancer	0.000574	0.00294	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Dactinomycin—testicular cancer	0.000573	0.00294	CcSEcCtD
Dextropropoxyphene—Confusional state—Etoposide—testicular cancer	0.000567	0.00291	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—testicular cancer	0.000565	0.00289	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Ifosfamide—testicular cancer	0.000563	0.00289	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—testicular cancer	0.000558	0.00286	CcSEcCtD
Dextropropoxyphene—Asthenia—Dactinomycin—testicular cancer	0.000558	0.00286	CcSEcCtD
Dextropropoxyphene—Tachycardia—Etoposide—testicular cancer	0.000549	0.00282	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—testicular cancer	0.000548	0.00281	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Cisplatin—testicular cancer	0.000548	0.00281	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dactinomycin—testicular cancer	0.000532	0.00273	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00053	0.00272	CcSEcCtD
Dextropropoxyphene—Vomiting—Bleomycin—testicular cancer	0.00053	0.00272	CcSEcCtD
Dextropropoxyphene—Drowsiness—Methotrexate—testicular cancer	0.000529	0.00271	CcSEcCtD
Dextropropoxyphene—Hypotension—Etoposide—testicular cancer	0.000526	0.0027	CcSEcCtD
Dextropropoxyphene—Rash—Bleomycin—testicular cancer	0.000526	0.00269	CcSEcCtD
Dextropropoxyphene—Dermatitis—Bleomycin—testicular cancer	0.000525	0.00269	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Ifosfamide—testicular cancer	0.000525	0.00269	CcSEcCtD
Dextropropoxyphene—Asthenia—Ifosfamide—testicular cancer	0.000511	0.00262	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Cisplatin—testicular cancer	0.000506	0.00259	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Etoposide—testicular cancer	0.000502	0.00257	CcSEcCtD
Dextropropoxyphene—Somnolence—Etoposide—testicular cancer	0.0005	0.00256	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—testicular cancer	0.0005	0.00256	CcSEcCtD
Dextropropoxyphene—Nausea—Bleomycin—testicular cancer	0.000495	0.00254	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—testicular cancer	0.000495	0.00254	CcSEcCtD
Dextropropoxyphene—Vomiting—Dactinomycin—testicular cancer	0.000494	0.00253	CcSEcCtD
Dextropropoxyphene—Rash—Dactinomycin—testicular cancer	0.00049	0.00251	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Ifosfamide—testicular cancer	0.000488	0.0025	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Etoposide—testicular cancer	0.000486	0.00249	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—testicular cancer	0.000482	0.00247	CcSEcCtD
Dextropropoxyphene—Constipation—Etoposide—testicular cancer	0.000481	0.00247	CcSEcCtD
Dextropropoxyphene—Dizziness—Ifosfamide—testicular cancer	0.000471	0.00242	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—testicular cancer	0.000468	0.0024	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—testicular cancer	0.000464	0.00238	CcSEcCtD
Dextropropoxyphene—Nausea—Dactinomycin—testicular cancer	0.000462	0.00237	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—testicular cancer	0.00046	0.00236	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—testicular cancer	0.000458	0.00235	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—testicular cancer	0.000457	0.00234	CcSEcCtD
Dextropropoxyphene—Vomiting—Ifosfamide—testicular cancer	0.000453	0.00232	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Cisplatin—testicular cancer	0.000453	0.00232	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—testicular cancer	0.000452	0.00232	CcSEcCtD
Dextropropoxyphene—Rash—Ifosfamide—testicular cancer	0.000449	0.0023	CcSEcCtD
Dextropropoxyphene—Dermatitis—Ifosfamide—testicular cancer	0.000449	0.0023	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—testicular cancer	0.000446	0.00229	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—testicular cancer	0.000445	0.00228	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—testicular cancer	0.000443	0.00227	CcSEcCtD
Dextropropoxyphene—Asthenia—Cisplatin—testicular cancer	0.000441	0.00226	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—testicular cancer	0.00044	0.00226	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000433	0.00222	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—testicular cancer	0.000429	0.0022	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—testicular cancer	0.000428	0.00219	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—testicular cancer	0.000428	0.00219	CcSEcCtD
Dextropropoxyphene—Nausea—Ifosfamide—testicular cancer	0.000423	0.00217	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Cisplatin—testicular cancer	0.00042	0.00215	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—testicular cancer	0.000418	0.00214	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—testicular cancer	0.000415	0.00213	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—testicular cancer	0.000415	0.00213	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—testicular cancer	0.000413	0.00212	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—testicular cancer	0.000412	0.00211	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—testicular cancer	0.000404	0.00207	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—testicular cancer	0.000401	0.00206	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—testicular cancer	0.0004	0.00205	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—testicular cancer	0.000397	0.00203	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—testicular cancer	0.000396	0.00203	CcSEcCtD
Dextropropoxyphene—Vomiting—Cisplatin—testicular cancer	0.000391	0.002	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—testicular cancer	0.000389	0.002	CcSEcCtD
Dextropropoxyphene—Rash—Cisplatin—testicular cancer	0.000387	0.00199	CcSEcCtD
Dextropropoxyphene—Dermatitis—Cisplatin—testicular cancer	0.000387	0.00198	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—testicular cancer	0.000387	0.00198	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Etoposide—testicular cancer	0.000385	0.00197	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—testicular cancer	0.000384	0.00197	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—testicular cancer	0.000381	0.00195	CcSEcCtD
Dextropropoxyphene—Dizziness—Etoposide—testicular cancer	0.000372	0.00191	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—testicular cancer	0.000371	0.0019	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—testicular cancer	0.00037	0.0019	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—testicular cancer	0.000367	0.00188	CcSEcCtD
Dextropropoxyphene—Nausea—Cisplatin—testicular cancer	0.000365	0.00187	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—testicular cancer	0.000364	0.00187	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—testicular cancer	0.000358	0.00183	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—testicular cancer	0.000358	0.00183	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—testicular cancer	0.000358	0.00183	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—testicular cancer	0.000355	0.00182	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—testicular cancer	0.000355	0.00182	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—testicular cancer	0.000355	0.00182	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—testicular cancer	0.000353	0.00181	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—testicular cancer	0.000347	0.00178	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—testicular cancer	0.000347	0.00178	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—testicular cancer	0.00034	0.00174	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—testicular cancer	0.00034	0.00174	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—testicular cancer	0.000337	0.00173	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—testicular cancer	0.000335	0.00172	CcSEcCtD
Dextropropoxyphene—Nausea—Etoposide—testicular cancer	0.000334	0.00171	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—testicular cancer	0.000331	0.00169	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—testicular cancer	0.000329	0.00168	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—testicular cancer	0.000325	0.00167	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—testicular cancer	0.000321	0.00164	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—testicular cancer	0.000318	0.00163	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—testicular cancer	0.000315	0.00161	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—testicular cancer	0.000314	0.00161	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—testicular cancer	0.00031	0.00159	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—testicular cancer	0.00031	0.00159	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—testicular cancer	0.000309	0.00159	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—testicular cancer	0.000308	0.00158	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—testicular cancer	0.000305	0.00156	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—testicular cancer	0.000301	0.00154	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—testicular cancer	0.000301	0.00154	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—testicular cancer	0.0003	0.00154	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—testicular cancer	0.000297	0.00152	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—testicular cancer	0.000295	0.00151	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—testicular cancer	0.000294	0.00151	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000291	0.00149	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—testicular cancer	0.000287	0.00147	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—testicular cancer	0.000286	0.00147	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—testicular cancer	0.000285	0.00146	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—testicular cancer	0.000285	0.00146	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—testicular cancer	0.000281	0.00144	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—testicular cancer	0.00028	0.00144	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—testicular cancer	0.000278	0.00142	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—testicular cancer	0.000278	0.00142	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—testicular cancer	0.000276	0.00141	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—testicular cancer	0.000273	0.0014	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000272	0.0014	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—testicular cancer	0.00027	0.00138	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—testicular cancer	0.000266	0.00137	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—testicular cancer	0.000264	0.00135	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—testicular cancer	0.00026	0.00133	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—testicular cancer	0.00026	0.00133	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—testicular cancer	0.000259	0.00133	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—testicular cancer	0.000258	0.00132	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—testicular cancer	0.000257	0.00132	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000252	0.00129	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—testicular cancer	0.00025	0.00128	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—testicular cancer	0.000249	0.00128	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—testicular cancer	0.000248	0.00127	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—testicular cancer	0.000242	0.00124	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—testicular cancer	0.000241	0.00123	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000239	0.00122	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—testicular cancer	0.000232	0.00119	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—testicular cancer	0.000231	0.00118	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—testicular cancer	0.000231	0.00118	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—testicular cancer	0.000226	0.00116	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—testicular cancer	0.000223	0.00114	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—testicular cancer	0.000216	0.00111	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—testicular cancer	0.000215	0.0011	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—testicular cancer	0.000214	0.0011	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—testicular cancer	0.000213	0.00109	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—testicular cancer	0.000212	0.00109	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—testicular cancer	0.000211	0.00108	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—testicular cancer	0.000209	0.00107	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—testicular cancer	0.000209	0.00107	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—testicular cancer	0.000201	0.00103	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—testicular cancer	0.0002	0.00103	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—testicular cancer	0.0002	0.00102	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—testicular cancer	0.000199	0.00102	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—testicular cancer	0.000199	0.00102	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—testicular cancer	0.000198	0.00101	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—testicular cancer	0.000193	0.000989	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—testicular cancer	0.000187	0.00096	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—testicular cancer	0.000186	0.000951	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—testicular cancer	0.000184	0.000943	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—testicular cancer	0.000184	0.000942	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—testicular cancer	0.000183	0.000937	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—testicular cancer	0.000173	0.000889	CcSEcCtD
